Raymond James Trust N.A. Buys 3,641 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Raymond James Trust N.A. boosted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 37.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,299 shares of the medical instruments supplier’s stock after acquiring an additional 3,641 shares during the period. Raymond James Trust N.A.’s holdings in DENTSPLY SIRONA were worth $360,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in XRAY. Advisors Asset Management Inc. raised its holdings in shares of DENTSPLY SIRONA by 99.3% in the 1st quarter. Advisors Asset Management Inc. now owns 14,548 shares of the medical instruments supplier’s stock worth $483,000 after purchasing an additional 7,248 shares during the period. Tidal Investments LLC lifted its position in shares of DENTSPLY SIRONA by 292.4% during the 1st quarter. Tidal Investments LLC now owns 24,149 shares of the medical instruments supplier’s stock valued at $802,000 after buying an additional 17,995 shares during the last quarter. Comerica Bank grew its stake in shares of DENTSPLY SIRONA by 2.9% during the 1st quarter. Comerica Bank now owns 42,568 shares of the medical instruments supplier’s stock worth $1,413,000 after acquiring an additional 1,205 shares during the period. Virtu Financial LLC purchased a new stake in DENTSPLY SIRONA in the 1st quarter worth about $1,027,000. Finally, Cetera Advisors LLC raised its stake in DENTSPLY SIRONA by 18.6% in the 1st quarter. Cetera Advisors LLC now owns 17,052 shares of the medical instruments supplier’s stock valued at $566,000 after acquiring an additional 2,675 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Up 2.3 %

Shares of NASDAQ XRAY opened at $19.64 on Thursday. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The business has a 50-day moving average of $22.97 and a 200-day moving average of $24.93. The firm has a market capitalization of $3.90 billion, a price-to-earnings ratio of -9.27, a PEG ratio of 1.92 and a beta of 1.02. DENTSPLY SIRONA Inc. has a 12 month low of $17.21 and a 12 month high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The business had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.49 EPS. Sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

Analysts Set New Price Targets

XRAY has been the subject of a number of research reports. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th. Robert W. Baird reduced their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, November 8th. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Needham & Company LLC reduced their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Finally, Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Seven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA currently has an average rating of “Hold” and an average price target of $29.50.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.